WHO Grade 2 Glioma

subtype

Identifier: CI-CAN-00007115
Entity page: /cancer/who-grade-2-glioma ↗
Edges: 334

Neighbours: 79 drugs10 trials
Drawn: 60 of 89 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
WHO Grade 2 Glioma investigated in trials for …INVESTIGATED_IN_TRIALSderived79 of 79show fewer
→ investigated in trials for	Temozolomidesmall molecule 33 trials (10 active) · roll-up of the cancer and its descendants	—	—	WHO Grade 2 Glioma	33	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 9 trials (4 active) · roll-up of the cancer and its descendants

WHO Grade 2 Glioma studied in …STUDIED_INderived10 of 255show all (up to 200)
→ studied in	NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 255 trials mapped (94 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03969706Phase 2 · completed Abemaciclib in Patients With Oligodendroglioma · condition mapped ONTOLOGY_EXACT · 255 trials mapped (94 active)	—	—	Adult Oligodendroglioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ALIAS · 255 trials mapped (94 active)	—	—	Astrocytoma, IDH-Mutant, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT04729959Phase 2 · active not recruiting Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 255 trials mapped (94 active)	—	—	Diffuse Astrocytoma, IDH-Wildtype	1	Observed	clinicaltrials	graph →
→ studied in	NCT07031765Phase 1 · active not recruiting Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma · condition mapped CURATED_BROADER · 255 trials mapped (94 active)	—	—	Oligodendroglioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07821112Phase 2 · not yet recruiting Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile® · condition mapped CURATED_BROADER · 255 trials mapped (94 active)	—	—	Oligodendroglioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 255 trials mapped (94 active)	—	—	Childhood Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped ONTOLOGY_EXACT · 255 trials mapped (94 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03528642Phase 1 · active not recruiting Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma · condition mapped ONTOLOGY_EXACT · 255 trials mapped (94 active)	—	—	Astrocytoma, IDH-Mutant, Grade 2	1	Observed	clinicaltrials	graph →
→ studied in	NCT07703436Phase 2 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease · condition mapped CURATED_BROADER · 255 trials mapped (94 active)	—	—	Oligodendroglioma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains